Characterization of cannabidiol-mediated cytochrome P450 inactivation
- 24 March 1993
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 45 (6), 1323-1331
- https://doi.org/10.1016/0006-2952(93)90286-6
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Inhibitory Effect of Cannabidiol Hydroxy-quinone, an Oxidative Product of Cannabidiol, on the Hepatic Microsomal Drug-Metabolizing Enzymes of Mice.Journal of Pharmacobio-Dynamics, 1991
- In vivo and in vitro metabolism of cannabidiol monomethyl ether and cannabidiol dimethyl ether in the guinea pig: On the formation mechanism of cannabielsoin-type metabolite from cannabidiol.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylaseBiochemistry, 1988
- The Cannabinoids as Potential AntiepilepticsThe Journal of Clinical Pharmacology, 1981
- Liver production of N‐alkylated porphyrins caused in mice by treatment with substituted dihydropyridinesFEBS Letters, 1981
- Liver cytosol catalyzed conjugation of reduced glutathione with a reactive metabolite of acetaminophenToxicology and Applied Pharmacology, 1979
- The formation of carbon monoxide during peroxidation of microsomal lipidsBiochemical and Biophysical Research Communications, 1976
- Cannabidiol and cannabinol in manCellular and Molecular Life Sciences, 1973
- A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1Journal of the American Chemical Society, 1965
- Structure of Cannabidiol. III. Reduction and CleavageJournal of the American Chemical Society, 1940